Yimusak Tablet Acting on Erectile Dysfunction Human Serum Differential Protein Combination and Its Screening Method and Application

An erectile dysfunction and differential protein technology, which is applied in the field of human serum differential protein combination and screening for erectile dysfunction of the penis, can solve the problems of unclear mechanism of action of Yimusak tablets, unclear signal transduction pathway of protein molecular mechanism, etc. The effect of treating impotence

Active Publication Date: 2021-11-30
XINJIANG MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the mechanism of action of Yimusak Tablets is not clear. After it acts on ED patients, the expression of proteins in the patient's body changes, the molecular mechanism of the proteins involved and the signal transduction pathways involved are not clear, so it cannot be well treated. Clinical application of Yimusak Tablets

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Yimusak Tablet Acting on Erectile Dysfunction Human Serum Differential Protein Combination and Its Screening Method and Application
  • Yimusak Tablet Acting on Erectile Dysfunction Human Serum Differential Protein Combination and Its Screening Method and Application
  • Yimusak Tablet Acting on Erectile Dysfunction Human Serum Differential Protein Combination and Its Screening Method and Application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0088] Example 1 A screening method for Yimusak tablets acting on human serum differential protein combinations for penile erectile dysfunction

[0089] The research subjects were selected from May 2015 to December 2016. 60 cases of impotence patients (before treatment) diagnosed in the Andrology Department of the First Affiliated Hospital of Xinjiang Medical University and the Fourth Affiliated Hospital (before treatment) were given 15 days of oral treatment with Yimusake Tablets ( 1.0g / day), 30 cases of normal healthy people. Standards for normal people go through physical examination, electrocardiogram (ECG), chest X-ray, blood and urine routine, blood sugar, liver and kidney function tests, no organic diseases of the heart, liver, brain, lung, kidney, endocrine, immune and other major organ systems, penile erection Normal function, normal sex life, IIEF-5 index ≥ 22. The diagnostic criteria of impotence refer to the definition of the National Institutes of Health in 1993....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
massaaaaaaaaaa
Login to view more

Abstract

The invention provides a differential protein combination of Yimusak tablet acting on human serum with erectile dysfunction, belonging to the technical field of screening of drug action target proteins, and the differential protein combination includes 45 kinds of proteins. The present invention is based on the screening, analysis and verification of serum differential protein markers in patients with ED treated with Yimusake Tablets, and obtains the expression changes of proteins in vivo after Yimusake Tablets act on ED patients. Systematic research has been carried out on the pathway, so as to further clarify the mechanism of the drug, guide the clinical application of the drug, and serve the secondary development of the drug. Moreover, after the differential protein combination is obtained, the present invention can intervene in the upstream and downstream proteins through targeted research on the signaling pathway of the target protein, so as to achieve the purpose of treating impotence.

Description

technical field [0001] The invention relates to the technical field of screening of drug action target proteins, in particular to a Yimusak tablet acting on human serum differential protein combination of penile erectile dysfunction and its screening method and application. Background technique [0002] Erectile dysfunction (ED) refers to the persistent or repeated inability to achieve or maintain a sufficient penile erection to complete a satisfactory sexual life, and also refers to the inability to continuously obtain or maintain a sufficient erection to complete a satisfactory sexual intercourse for at least 6 months . ED is a common sexual dysfunction in men, mainly affecting men over 40 years old, and its prevalence increases with age. According to research, 52% of men aged 40 to 70 suffer from different degrees of erectile dysfunction. In recent years, with the gradual increase of pressure in life, work, psychology and other aspects, the prevalence of ED has been incr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/68G01N30/88
CPCG01N30/88G01N33/6848
Inventor 阿地力江·伊明刘凤霞阿卜杜热伊木江·如则许鹏王岩斌毛吾兰·买买提依明马文静斯依提·阿木提
Owner XINJIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap